Article information
Full text is only aviable in PDF
Bibliografía
[1.]
F. Blanco Rodriguez.
Orientaciones acerca del tratamiento de la Tuberculosis Pulmonar.
Bol. Cons. Col Med. Esp., 83 (1954), pp. 25
[2.]
F.J. Guerra Sanz.
Tratamiento actual de la Tuberculosis Pulmonar Abierta.
Publicaciones Lederle, (1969),
[3.]
J. Wallace Fox.
The scope of the controlled clinical trial, illustred by studies of Pulmonary Tuberculosis.
Bull. World. Health. Org., 45 (1971), pp. 559
[4.]
F.J. Guerra Sanz.
Side effects during intermittent Rifampicin and Ethambutol Treatment. A preliminary report.
Scand. Jour. Resp. Dis. Suppl., 84 (1973), pp. 160
[5.]
E. Regli Fernandez, Bachiller Cabezon.
Intolerancias en el curso de un tratamiento controlado con Rifampicina y Ethambutol.
«Symposium Mediterráneo de Tisiología», (1973),
[6.]
F.J. Guerra Sanz, J.J. Martinez Cuesta.
A preliminary report of the results and side effects obtained during retreatment of pulmonary Tuberculosis with Intermittent Rifampicin and Ethambutol Regimens.
Excerpta Medica,
[7.]
A. Rouillon.
Comment motiver les malades a entrependre et a poursuivre leur traitment.
Bull. Un. Int. Cont. Tub., 42 (1969), pp. 173
[8.]
Guerra Sanz, F.J. y Rey Duran, R. : Criterios y Normas Generales sobre Quimioterapia antituberculosa. Parte II, en preparación.
[9.]
F.R. Johnston, H.K. Wildrick.
The impact of chemotherapy on the case of patients with Tuberculosis.
Am. Rev. Resp. Dis., 109 (1974), pp. 636
[10.]
L. Velasco, A. De Ortega.
Resistencia Bacteriana primaria en la Tuberculosis del adulto.
Med. Clin., 60 (1973), pp. 459
[11.]
P. March Ayuela.
Resistencias Primarias y secundarias a las drogas antituberculosas.
Rev. Ibys, 25 (1970), pp. 137
[12.]
F. Grumbach, G. Canetti, J. Grosset, M. Le Lirzin.
Late results of Longterm intermittent chemotherapy of advanced murine tuberculosis: Limits of the murine model.
Tubercle, 48 (1967), pp. 11
[13.]
F. Crumbach, G. Canetti, M. Le Lirzin.
Caractere durable de la sterilization de la tuberculose experiméntale de la souris par Tassociation rifampicine-isoniazide. Epreuve de la cortisone.
Rev. Tuberc. Pneumol., 34 (1970), pp. 311
[14.]
G. Canetti, J. Grosset, M. Le Lirzin.
La sterilisation des lesions tuberculeuses sous chimiotherapie chez Thomme.
Bull Un. Int. Cont. Tub., 43 (1970), pp. 347
[15.]
G. Canetti.
Host factors and Chemotherapy of tuberculosis.
V. C. Barry Chemotherapy of Tuberculosis, Butterworth, (1963),
[16.]
N. Rist.
Origine et developpement de la resistence du bacille de Koch aux medicaments. La Tuberculose.
Collection Lepetit, (1971),
[17.]
G. Canetti.
Present aspects of bacterial resistance in tuberculosis.
Am. Rev. Resp. Dis., 92 (1965), pp. 687
[18.]
F. Grumbach, N. Rist.
Activite antitubercfleuse de la Rifampicine, derive de la Rifamycine S.V.
Rev. Tub. Pneum., 31 (1967), pp. 749
[19.]
D.A. Mitchinson.
Bacteriological mechanisms in recent controlled chemotherapy studies.
Bull. Un. Int. Con. Tub., 43 (1970), pp. 322
[21.]
A. Gyselen, J. Verbist.
A cooperative study on rifampicin in original treat-ment of advanced pulmonary tuberculosis.
Act. Tub. Pneum. Belg., 60 (1969), pp. 563
[24.]
J. Verbist.
Intermittent therapy with Rifampin once a week in advanced Pulmonary Tuberculosis.
Chest, 61 (1972), pp. 555
[25.]
M. Zierski.
Effects secondaires observes sous traitment intermitten par la Rifampicine. Revue generale.
Bull Un. Int. Cont. Tub., 48 (1973), pp. 128
[26.]
M. Aquinas.
A controlled clinical trial of small doses of Rifampicin in the prevention of adverse reaction to the drug a once weekiy régimen of chemotherapy in Hongkong.
Excerpta Medica,
[27.]
G. Brouet.
Estudio cooperativo de tratamientos antibacilares de corta duración en 14 Centros franceses.
Symposium del Mediterráneo., (1973),
[28.]
F. Poppe De Figueredo.
Chimoterapie de courte durée dans la tuberculose pulmonaire jamais tratée (bilan an 20-7-1972).
Bull Un Int. Con. Tuberc., 48 (1973), pp. 150
[29.]
F. Poppe De Figueredo.
Short duration chemotherapy of pulmonary tuberculosis: A pilot trial.
Excerpta Medica,
[30.]
East African/British Medical Research Council.
Controlled Clinical Trial of four short-course (6 months) regimens of chemotherapy for treatment of pulmonary tuberculosis.
Lancet, 1 (1973), pp. 1.332
[31.]
East African Tuberculosis Investigaron Center.
Short course (6 montsh) treatment of pulmonary tuberculosis.
Excerpta Medica,
Copyright © 1975. Sociedad Española de Neumología y Cirugía Torácica
